Aboujaoude Nour, Iskandar Maria, Tannouri Fadi
Department of Radiology, Notre Dame des Secours CHU, Byblos, Lebanon.
Department of Radiology, Hospital Erasme, Brussels, Belgium.
Eur J Radiol Open. 2020 Dec 11;8:100302. doi: 10.1016/j.ejro.2020.100302. eCollection 2021.
We report a case of a patient diagnosed with pulmonary endometriosis and successfully treated with a GnRH agonist. This 34-year-old mother presented cyclic hemoptysis since 4-month. A non-enhanced computed tomography made at the end of the luteal phase revealed a solitary lung nodule with no other abnormalities. A contrast enhanced computed tomography conducted during menses revealed a ground glass opacity extending from the nodule towards hilum. The diagnosis of pulmonary endometriosis was established taking into account the clinical presentation and the imaging findings. Medical treatment by Triptorelin pamoate (Decapeptyl LP® 3 mg Ipsen Pharma, France), a GnRH agonist, was proposed for a period of 6 months. A CT scan performed 3 months after the end of the treatment shows a complete disappearance of the endometriosis nodular lesion.
我们报告一例被诊断为肺子宫内膜异位症并成功接受促性腺激素释放激素（GnRH）激动剂治疗的患者。这位34岁的母亲自4个月前开始出现周期性咯血。黄体期末进行的非增强计算机断层扫描显示一个孤立的肺结节，无其他异常。月经期间进行的增强计算机断层扫描显示从结节向肺门延伸的磨玻璃影。结合临床表现和影像学检查结果确诊为肺子宫内膜异位症。建议使用GnRH激动剂曲普瑞林棕榈酸酯（法国益普生制药公司的达必佳LP®3mg）进行为期6个月的药物治疗。治疗结束3个月后进行的CT扫描显示子宫内膜异位结节性病变完全消失。
